News Mydecine Innovations Group Inc. NEO Exchange

Equities

MYCO

CA62849F2008

End-of-day quote NEO Exchange Other stock markets 06:00:00 2023-10-05 pm EDT			5-day change	1st Jan Change
0.175 ^CAD	+45.83%		+29.63%	-61.11%

Feb. 23	Mydecine Innovations Closes Partial Debt Settlement	MT
Feb. 02	Mydecine Innovations Group Inc Announces Resignation of Neil Stevenson-Moore as Director	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Mydecine Innovations Group Inc. Announces Share for Debt Settlement	Mar. 20	AQ
Mydecine Innovations Closes Partial Debt Settlement	Feb. 23	MT
Mydecine Innovations Group Receives Two Notice of Allowances from USPTO for its MYCO-005 and MYCO-006 Family of Compounds	Feb. 07	GL
Mydecine Innovations Group Receives Two Notice of Allowances from USPTO for its MYCO-005 and MYCO-006 Family of Compounds	Feb. 07	AQ
Mydecine Innovations Group Announces Director Resignation	Feb. 02	GL
Mydecine Innovations Group Inc Announces Resignation of Neil Stevenson-Moore as Director	Feb. 02	CI
Mydecine Innovations Group Receives Notice of Allowance from USPTO For MYCO-005 Compound	Dec. 18	MT
Mydecine Innovations Group Receives Notice of Allowance from USPTO for its MYCO-005 Compound	Dec. 18	GL
Mydecine Announces Update Regarding the Special Access Program	Nov. 28	GL
Mydecine Innovations Group Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 17	CI
Mydecine Innovations Group Files Prospectus Supplement, Announces Closing Under Share Subscription Agreements	23-10-31	GL
Mydecine Innovations Group Files Prospectus Supplement, Announces Closing Under Share Subscription Agreements	23-10-31	AQ
Mydecine Innovations Group Provided Q4 2023 Business Update	23-10-26	MT
Mydecine Provides Q4 2023 Business Update	23-10-26	GL
Mydecine Provides Q4 2023 Business Update	23-10-26	AQ
Mydecine Innovations Group gearing up for human trials after completing Aquis listing	23-10-18	AQ
Mydecine Innovations Group Announces Admission to Trading on the AQSE Growth Market in London, UK	23-10-12	GL
Mydecine Innovations Group Announces Admission to Trading on the AQSE Growth Market in London, UK	23-10-12	AQ
Mydecine Innovations Group Brief: Announced Admission to Trading on AQSE Growth Market in London, UK and First Day of Dealings	23-10-10	MT
Mydecine Innovations Group Announces Admission to Trading on the AQSE Growth Market in London, UK and First Day of Dealings	23-10-10	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Mydecine Innovations Group Inc. NEO Exchange

Equities

MYCO

CA62849F2008

Summary

Filters